Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Rituximab in Subjects With International Society of Nephrology/Renal Pathology Society (ISN/RPS) 2003 Class III or IV Lupus Nephritis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of rituximab in ISN/RPS 2003 Class III or IV lupus nephritis completed and results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Lupus Nephritis | Phase 3 | Status: COMPLETED | Results posted: 2010-02-23